Literature DB >> 29242123

Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.

J Ramírez1, J M Górriz2, A Ortiz3, F J Martínez-Murcia4, F Segovia4, D Salas-Gonzalez4, D Castillo-Barnes4, I A Illán4, C G Puntonet5.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common cause of dementia in the elderly and affects approximately 30 million individuals worldwide. Mild cognitive impairment (MCI) is very frequently a prodromal phase of AD, and existing studies have suggested that people with MCI tend to progress to AD at a rate of about 10-15% per year. However, the ability of clinicians and machine learning systems to predict AD based on MRI biomarkers at an early stage is still a challenging problem that can have a great impact in improving treatments.
METHOD: The proposed system, developed by the SiPBA-UGR team for this challenge, is based on feature standardization, ANOVA feature selection, partial least squares feature dimension reduction and an ensemble of One vs. Rest random forest classifiers. With the aim of improving its performance when discriminating healthy controls (HC) from MCI, a second binary classification level was introduced that reconsiders the HC and MCI predictions of the first level.
RESULTS: The system was trained and evaluated on an ADNI datasets that consist of T1-weighted MRI morphological measurements from HC, stable MCI, converter MCI and AD subjects. The proposed system yields a 56.25% classification score on the test subset which consists of 160 real subjects. COMPARISON WITH EXISTING METHOD(S): The classifier yielded the best performance when compared to: (i) One vs. One (OvO), One vs. Rest (OvR) and error correcting output codes (ECOC) as strategies for reducing the multiclass classification task to multiple binary classification problems, (ii) support vector machines, gradient boosting classifier and random forest as base binary classifiers, and (iii) bagging ensemble learning.
CONCLUSIONS: A robust method has been proposed for the international challenge on MCI prediction based on MRI data. The system yielded the second best performance during the competition with an accuracy rate of 56.25% when evaluated on the real subjects of the test set.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ANOVA feature selection; Alzheimer's disease; Bagging; Computer-aided diagnosis; Machine learning; Magnetic resonance imaging; Mild cognitive impairment; One vs. Rest classification; Partial least squares; Random forests

Mesh:

Year:  2017        PMID: 29242123     DOI: 10.1016/j.jneumeth.2017.12.005

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  12 in total

1.  A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease.

Authors:  Shaker El-Sappagh; Jose M Alonso; S M Riazul Islam; Ahmad M Sultan; Kyung Sup Kwak
Journal:  Sci Rep       Date:  2021-01-29       Impact factor: 4.379

2.  Autosomal Dominantly Inherited Alzheimer Disease: Analysis of genetic subgroups by Machine Learning.

Authors:  Diego Castillo-Barnes; Li Su; Javier Ramírez; Diego Salas-Gonzalez; Francisco J Martinez-Murcia; Ignacio A Illan; Fermin Segovia; Andres Ortiz; Carlos Cruchaga; Martin R Farlow; Chengjie Xiong; Neil R Graff-Radford; Peter R Schofield; Colin L Masters; Stephen Salloway; Mathias Jucker; Hiroshi Mori; Johannes Levin; Juan M Gorriz
Journal:  Inf Fusion       Date:  2020-01-07       Impact factor: 12.975

3.  Quantifying performance of machine learning methods for neuroimaging data.

Authors:  Lee Jollans; Rory Boyle; Eric Artiges; Tobias Banaschewski; Sylvane Desrivières; Antoine Grigis; Jean-Luc Martinot; Tomáš Paus; Michael N Smolka; Henrik Walter; Gunter Schumann; Hugh Garavan; Robert Whelan
Journal:  Neuroimage       Date:  2019-06-05       Impact factor: 7.400

Review 4.  How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database.

Authors:  Stavros I Dimitriadis; Dimitris Liparas
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

5.  Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease.

Authors:  Diego Castillo-Barnes; Javier Ramírez; Fermín Segovia; Francisco J Martínez-Murcia; Diego Salas-Gonzalez; Juan M Górriz
Journal:  Front Neuroinform       Date:  2018-08-14       Impact factor: 4.081

6.  Weighted Random Support Vector Machine Clusters Analysis of Resting-State fMRI in Mild Cognitive Impairment.

Authors:  Xia-An Bi; Qian Xu; Xianhao Luo; Qi Sun; Zhigang Wang
Journal:  Front Psychiatry       Date:  2018-07-25       Impact factor: 4.157

7.  Deep Learning and Multiplex Networks for Accurate Modeling of Brain Age.

Authors:  Nicola Amoroso; Marianna La Rocca; Loredana Bellantuono; Domenico Diacono; Annarita Fanizzi; Eufemia Lella; Angela Lombardi; Tommaso Maggipinto; Alfonso Monaco; Sabina Tangaro; Roberto Bellotti
Journal:  Front Aging Neurosci       Date:  2019-05-22       Impact factor: 5.750

8.  New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.

Authors:  Carmen Peña-Bautista; Claire Vigor; Jean-Marie Galano; Camille Oger; Thierry Durand; Inés Ferrer; Ana Cuevas; Rogelio López-Cuevas; Miguel Baquero; Marina López-Nogueroles; Máximo Vento; David Hervás-Marín; Ana García-Blanco; Consuelo Cháfer-Pericás
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

9.  Inter-Cohort Validation of SuStaIn Model for Alzheimer's Disease.

Authors:  Damiano Archetti; Alexandra L Young; Neil P Oxtoby; Daniel Ferreira; Gustav Mårtensson; Eric Westman; Daniel C Alexander; Giovanni B Frisoni; Alberto Redolfi
Journal:  Front Big Data       Date:  2021-05-20

10.  Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.

Authors:  Maryam Ahmadzadeh; Gregory J Christie; Theodore D Cosco; Sylvain Moreno
Journal:  Syst Rev       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.